Cytori Therapeutics To Present at the 25th Annual Roth Conference on March 18
Mar 11th 2013 8:35AM
Updated Mar 11th 2013 9:00AM
Cytori Therapeutics To Present at the 25 th Annual Roth Conference on March 18
The presentation will be webcast and may be accessed under "Webcasts" under Cytori's Investor Relations section of the website. The webcast can be viewed live and will be available for replay after the presentation on the Company's website.
Cytori Therapeutics, Inc. is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple "ischemic" conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori's proprietary technologies and products, including the Celution® system product family. www.cytori.com
Cytori Therapeutics Inc.
Megan McCormick, +1-858-875-5279
KEYWORDS: United States North America California
The article Cytori Therapeutics To Present at the 25th Annual Roth Conference on March 18 originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.